Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T13:40:35.275Z.
Calculation as of: 2026-10-06T13:40:35.275Z.
Quote observation: 2026-10-06T13:39:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$559702.00
EV/Sales Ratio
0.95x
TTM Avg
22.73x
3Y Avg
233.34x
5Y Avg
409.95x
Market Cap
$797661.00
EV/Sales Ratio
N/A
TTM Avg
2170.65x
3Y Avg
2189.01x
5Y Avg
2189.01x
Market Cap
$883067.00
EV/Sales Ratio
N/A
TTM Avg
78.84x
3Y Avg
47.25x
5Y Avg
902.93x
Market Cap
$867353.00
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$893920.00
EV/Sales Ratio
N/A
TTM Avg
48327.79x
3Y Avg
43699.06x
5Y Avg
43699.06x
Market Cap
$1.03M
EV/Sales Ratio
N/A
TTM Avg
26520.58x
3Y Avg
26520.58x
5Y Avg
26520.58x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61573.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | 0.95x | 22.73x | 233.34x | 409.95x |
| CDT Equity Inc. (CDT)vs › | $685717.00 | 0.67x | 1.27x | 1.27x | 1.27x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $797661.00 | N/A | 2170.65x | 2189.01x | 2189.01x |
| Decoy Therapeutics Inc. (DCOY)vs › | $883067.00 | N/A | 78.84x | 47.25x | 902.93x |
| Bone Biologics Corporation (BBLG)vs › | $867353.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | 48327.79x | 43699.06x | 43699.06x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | N/A | 26520.58x | 26520.58x | 26520.58x |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
